C4 Therapeutics (CCCC) Long-Term Investments (2021 - 2025)
Historic Long-Term Investments for C4 Therapeutics (CCCC) over the last 5 years, with Q3 2025 value amounting to $7.9 million.
- C4 Therapeutics' Long-Term Investments fell 7261.73% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 7261.73%. This contributed to the annual value of $22.4 million for FY2024, which is 2016.92% down from last year.
- Latest data reveals that C4 Therapeutics reported Long-Term Investments of $7.9 million as of Q3 2025, which was down 7261.73% from $8.4 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Long-Term Investments ranged from a high of $142.2 million in Q4 2021 and a low of $7.9 million during Q3 2025
- For the 5-year period, C4 Therapeutics' Long-Term Investments averaged around $46.9 million, with its median value being $32.5 million (2021).
- Per our database at Business Quant, C4 Therapeutics' Long-Term Investments soared by 30153.25% in 2022 and then plummeted by 7844.14% in 2023.
- C4 Therapeutics' Long-Term Investments (Quarter) stood at $142.2 million in 2021, then crashed by 57.13% to $61.0 million in 2022, then crashed by 54.06% to $28.0 million in 2023, then fell by 20.17% to $22.4 million in 2024, then crashed by 64.78% to $7.9 million in 2025.
- Its Long-Term Investments was $7.9 million in Q3 2025, compared to $8.4 million in Q2 2025 and $19.6 million in Q1 2025.